Myoblast-Mediated Gene Therapy Improves Functional Collateralization in Chronic Cerebral Hypoperfusion [Basic Sciences]
Conclusions—
Myoblast-mediated VEGF supplementation at the target site of an EMS could help overcome the clinical dilemma of poor surgical revascularization results and provide protection from ischemic stroke.
Source: Stroke - Category: Neurology Authors: Hecht, N., Marushima, A., Nieminen, M., Kremenetskaia, I., von Degenfeld, G., Woitzik, J., Vajkoczy, P. Tags: Cerebrovascular disease/stroke, By-pass procedures Basic Sciences Source Type: research
More News: Brain | Gene Therapy | Genetics | Ischemic Stroke | Laser Surgery | Neurology | Stroke | Study